Sartorius Stedim Biotech SA: Half-year liquidity contract statement for Sartorius Stedim Biotech

Metadata

Provider:

EQS

Retrieved on:

Mardi, juillet 5, 2022

Information

Geotags:

FRANKREICH

Stock Symbol:

ISIN:FR0013154002

Résumé

Key Points:

Sartorius Stedim Biotech SA

Sartorius Stedim Biotech SA: Half-year liquidity contract statement for Sartorius Stedim Biotech

05-Jul-2022 / 14:03 CET/CEST

Dissemination of a French Regulatory News, transmitted by EQS Group.

The issuer is solely responsible for the content of this announcement.

Aubagne, July 1, 2022

Half-year liquidity contract statement for Sartorius Stedim Biotech

Under the liquidity contract entered into between Sartorius Stedim Biotech and Kepler Cheuvreux, the following resources appeared on the liquidity account on June 30th 2022:

20,241 shares
€ 3,286,293.04
Number of executions on buy side on semester: 4,639
Number of executions on sell side on semester: 4,205
Traded volume on buy side on semester: 186,508 shares for € 64,215,074.25
Traded volume on sell side on semester: 169,628 shares for € 57,532,559.42

As a reminder, the following resources appeared on the last half year statement on 31 December 2021 on the liquidity account:

3,361 shares
€ 9,978,179.44
Number of executions on buy side on semester: 2,810
Number of executions on sell side on semester: 2,600
Traded volume on buy side on semester: 95,701 shares for € 44,247,756.63
Traded volume on sell side on semester: 94,714 shares for € 45,073,166.52

The following resources appeared on the liquidity account when the activity started:

0 shares
€ 10,000,000.00

The implementation of this report is carried out in accordance with AMF Decision N°2021-01 of June 22nd 2021 renewing the implementation of liquidity contracts for shares as an accepted market practice.

A profile of Sartorius Stedim Biotech

Sartorius Stedim Biotech is a leading international partner of the biopharmaceutical industry. As a total solutions provider, the company helps its customers to manufacture biotech medications safely, rapidly and economically. Headquartered in Aubagne, France, Sartorius Stedim Biotech is quoted on the Eurolist of Euronext Paris. With its own manufacturing and R&D sites in Europe, North America and Asia and an international network of sales companies, Sartorius Stedim Biotech has a global reach. The Group has been annually growing by double digits on average and has been regularly expanding its portfolio by acquisitions of complementary technologies. In 2021, the company employed more than 10,400 people, and earned sales revenue of around 2.89 billion euros.

Contact

Petra Müller

Head of Investor Relations

+49 (0)551.308.6035

[email protected]

Sartorius Stedim Biotech S.A.

Z.I. Les Paluds

Avenue de Jouques, CS 91051

13781 Aubagne Cedex, France

Phone: +33.(0)4.42.84.56.00

Fax: +33.(0)4.42.84.56.19

www.sartorius.com

	Buy side			Sell side
	Number of executions	Number of shares	Traded volume in EUR	Number of executions	Number of shares	Traded volume in EUR
TOTAL	4,639	186,508	64,215,074.25	4,205	169,628	57,532,559.42
03/01/2022	17	700	335,202.00	7	300	146,901.00
04/01/2022	163	6,500	2,963,480.00	15	500	243,800.00
05/01/2022	86	2,100	912,702.00	3	100	43,900.00
06/01/2022	44	1,300	551,499.00	7	400	170,200.00
07/01/2022	18	500	209,800.00	5	200	84,800.00
10/01/2022	122	5,500	2,206,820.00	-	-	-
11/01/2022	23	900	361,530.00	49	2,900	1,185,404.00
12/01/2022	15	342	138,595.50	22	800	329,504.00
13/01/2022	112	3,958	1,563,726.64	-	-	-
14/01/2022	91	2,600	971,048.00	3	200	75,100.00
17/01/2022	45	900	326,403.00	41	1,500	557,775.00
18/01/2022	41	1,300	477,100.00	1	100	36,780.00
19/01/2022	25	800	293,592.00	68	2,201	821,083.05
20/01/2022	29	1,215	453,231.45	53	2,199	830,672.25
21/01/2022	54	1,785	673,498.35	37	1,300	493,103.00
24/01/2022	62	2,400	887,928.00	31	1,300	484,601.00
25/01/2022	46	2,000	720,260.00	28	700	256,928.00
26/01/2022	21	500	179,000.00	49	1,900	693,709.00
27/01/2022	63	1,884	669,856.20	49	2,032	736,315.52
28/01/2022	-	-	-	50	1,400	523,194.00
31/01/2022	1	100	38,000.00	61	900	346,806.00
01/02/2022	3	200	77,600.00	21	800	313,304.00
02/02/2022	-	-	-	18	600	238,500.00
03/02/2022	39	1,200	466,632.00	9	300	118,500.00
04/02/2022	-	-	-	16	900	351,027.00
07/02/2022	28	1,000	385,500.00	33	1,400	545,720.00
08/02/2022	125	5,100	1,908,318.00	19	1,009	395,195.03
09/02/2022	-	-	-	49	3,400	1,286,968.00
10/02/2022	50	3,405	1,267,953.90	27	900	339,147.00
11/02/2022	51	3,195	1,163,906.55	27	1,200	443,340.00
14/02/2022	78	2,316	814,838.28	4	200	71,100.00
15/02/2022	-	-	-	60	3,000	1,080,030.00
16/02/2022	33	1,700	605,472.00	-	-	-
17/02/2022	17	951	335,807.61	30	800	287,704.00
18/02/2022	61	2,297	785,459.15	-	-	-
21/02/2022	24	903	297,565.59	14	900	297,900.00
22/02/2022	42	1,000	321,400.00	21	1,000	327,450.00
23/02/2022	13	500	166,000.00	7	300	100,599.00
24/02/2022	69	1,815	584,411.85	21	1,800	595,008.00
25/02/2022	-	-	-	26	800	270,848.00
28/02/2022	15	500	167,400.00	44	1,600	553,344.00
01/03/2022	45	1,600	535,200.00	38	2,100	718,095.00
02/03/2022	32	800	271,352.00	8	400	139,500.00
03/03/2022	12	800	266,800.00	-	-	-
04/03/2022	43	1,600	515,120.00	1	100	33,700.00
07/03/2022	61	1,100	335,995.00	30	1,400	443,394.00
08/03/2022	35	1,300	397,696.00	-	-	-
09/03/2022	-	-	-	27	1,400	437,500.00
10/03/2022	-	-	-	16	600	193,500.00
11/03/2022	19	800	249,920.00	22	1,100	349,195.00
14/03/2022	10	400	125,400.00	49	2,500	806,250.00

	Buy side			Sell side
	Number of executions	Number of shares	Traded volume in EUR	Number of executions	Number of shares	Traded volume in EUR
TOTAL	4,639	186,508	64,215,074.25	4,205	169,628	57,532,559.42
15/03/2022	18	1,056	344,087.04	48	1,800	593,298.00
16/03/2022	-	-	-	61	2,400	822,192.00
17/03/2022	31	1,700	600,406.00	33	1,500	533,865.00
18/03/2022	23	1,200	423,000.00	42	2,000	717,540.00
21/03/2022	38	2,200	795,410.00	34	1,700	618,392.00
22/03/2022	34	1,346	480,293.18	27	1,400	504,406.00
23/03/2022	42	2,000	724,300.00	29	1,003	367,218.36
24/03/2022	31	1,500	529,905.00	16	900	320,499.00
25/03/2022	19	904	325,195.92	59	3,097	1,126,564.72
28/03/2022	22	1,100	394,295.00	55	2,100	763,392.00
29/03/2022	5	200	74,300.00	119	4,200	1,592,052.00
30/03/2022	44	2,000	768,500.00	31	1,200	464,304.00
31/03/2022	38	1,900	718,105.00	18	900	345,699.00
01/04/2022	17	700	260,001.00	36	1,600	601,904.00
04/04/2022	10	300	115,200.00	58	2,400	927,408.00
05/04/2022	9	600	234,702.00	51	1,900	748,087.00
06/04/2022	56	2,338	916,308.96	29	1,100	434,896.00
07/04/2022	34	1,700	665,108.00	44	1,900	746,909.00
08/04/2022	76	3,000	1,149,990.00	21	217	85,949.36
11/04/2022	72	3,100	1,131,531.00	11	600	223,398.00
12/04/2022	65	2,900	1,029,210.00	49	2,200	792,000.00
13/04/2022	38	2,100	741,426.00	24	1,200	428,400.00
14/04/2022	50	1,800	623,394.00	27	1,200	420,204.00
19/04/2022	43	1,700	567,103.00	36	1,600	536,848.00
20/04/2022	13	631	211,138.91	45	2,000	678,200.00
21/04/2022	58	2,600	909,506.00	121	3,400	1,201,900.00
22/04/2022	90	4,000	1,323,920.00	18	900	304,101.00
25/04/2022	72	2,300	716,634.00	58	1,800	566,100.00
26/04/2022	46	2,300	700,304.00	6	300	93,201.00
27/04/2022	64	2,500	741,300.00	54	2,300	689,448.00
28/04/2022	12	600	181,200.00	66	2,500	764,350.00
29/04/2022	15	900	280,197.00	43	1,500	471,180.00
02/05/2022	60	3,300	990,264.00	46	1,802	546,204.22
03/05/2022	34	1,400	422,996.00	47	1,698	517,805.10
04/05/2022	31	1,800	541,800.00	19	642	194,821.32
05/05/2022	36	1,900	575,263.00	61	2,100	648,501.00
06/05/2022	30	1,400	412,104.00	20	1,100	325,468.00
09/05/2022	35	1,600	464,896.00	24	1,200	351,204.00
10/05/2022	22	1,055	303,249.20	35	1,500	434,205.00
11/05/2022	29	1,500	432,795.00	54	2,200	640,816.00
12/05/2022	86	2,300	647,220.00	16	993	279,936.63
13/05/2022	1	23	6,647.00	86	2,900	844,016.00
16/05/2022	43	1,800	542,646.00	71	2,500	760,700.00
17/05/2022	22	1,200	362,604.00	37	1,200	364,644.00
18/05/2022	28	1,600	479,328.00	21	713	216,031.87
19/05/2022	54	1,300	381,004.00	44	2,287	679,810.75
20/05/2022	18	569	173,607.59	36	1,377	422,394.75
23/05/2022	37	2,000	620,200.00	51	1,900	593,959.00
24/05/2022	38	1,400	431,704.00	31	1,400	434,994.00

	Buy side			Sell side
	Number of executions	Number of shares	Traded volume in EUR	Number of executions	Number of shares	Traded volume in EUR
TOTAL	4,639	186,508	64,215,074.25	4,205	169,628	57,532,559.42
25/05/2022	38	1,698	519,859.68	33	1,301	401,345.49
26/05/2022	26	1,200	368,196.00	30	1,107	340,889.58
27/05/2022	-	-	-	62	2,092	657,766.64
30/05/2022	-	-	-	33	1,300	425,906.00
31/05/2022	51	1,900	617,215.00	29	1,100	361,295.00
01/06/2022	44	2,000	630,300.00	20	800	254,504.00
02/06/2022	19	900	281,799.00	58	2,300	725,098.00
03/06/2022	54	1,800	582,408.00	41	1,200	393,420.00
06/06/2022	20	1,022	327,734.96	36	1,400	450,730.00
07/06/2022	33	1,800	573,894.00	28	1,600	512,608.00
08/06/2022	18	800	256,704.00	34	1,308	421,712.28
09/06/2022	34	1,433	457,098.34	23	900	288,603.00
10/06/2022	63	2,267	714,105.00	30	1,200	382,692.00
13/06/2022	76	2,100	638,232.00	28	900	275,499.00
14/06/2022	44	2,000	600,900.00	49	1,300	399,594.00
15/06/2022	29	1,144	339,470.56	46	1,500	449,175.00
16/06/2022	62	2,056	602,305.20	8	400	117,900.00
17/06/2022	40	1,900	550,791.00	57	1,950	574,411.50
20/06/2022	44	2,000	565,900.00	21	1,200	345,024.00
21/06/2022	15	900	252,900.00	27	1,000	282,700.00
22/06/2022	19	1,000	272,300.00	29	1,600	443,408.00
23/06/2022	23	1,000	277,280.00	33	1,700	477,496.00
24/06/2022	1	100	28,500.00	52	1,800	532,008.00
27/06/2022	-	-	-	38	1,100	343,101.00
28/06/2022	27	1,500	459,405.00	15	700	216,398.00
29/06/2022	46	1,424	420,735.04	26	1,400	418,040.00
30/06/2022	41	1,476	433,722.60	35	1,700	504,424.00

Regulatory filing PDF file

File: Half-year liquidity contract statement for Sartorius Stedim Biotech


Language:	English
Company:	Sartorius Stedim Biotech SA
	Avenue de Jouques
	13781 Aubagne
	France
Phone:	+33 44 284 5600
E-mail:	[email protected]
Internet:	www.sartorius-stedim.com
ISIN:	FR0013154002
Euronext Ticker:	DIM
AMF Category:	Share buyback / Disposal of own shares / Information relating to the liquidity contract
EQS News ID:	1391143


End of Announcement	EQS News Service

1391143 05-Jul-2022 CET/CEST